Home » Features » Education » Scripps Research Institute

Scripps Research Institute

About Scripps Research Institute

In June 09, Scripps Associate Professor Xiang-Lei Yang further validates aTyr Pharma's Discovery Engine for Proprietary Drugs

Scripps Research Institute in News

Boehringer Ingelheim Will Invest 11 Billion Euros in Research and Development in the Next Five Years to Accelerate the Discovery of Next Generation Medical Breakthroughs
Business Wire IndiaBoehringer Ingelheim is launching a new research and development (R&D) strategy and a five-year R&D investment programme. This new plan was announced at its R&D press conference in Berlin. The company pledges to invest a total of 11 billion euros in its new R&D programme over the next five years

Boehringer Ingelheim partners with leading scientific institutions in inflammatory bowel disease research
Business Wire India

EQM Capital LLC Introduces Investments4Impact Portfolios That Align Investing and Charitable Giving
EQM Capital LLC, ("EQM"), a San Diego-based registered investment advisor, introduced the Investments4Impact portfolios last October

diaDexus, Inc. Announces Appointment of John Curnutte, M.D., Ph.D. to Its Board of Directors
diaDexus, Inc. (OTCQB: DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced the appointment of John Curnutte, M.D., Ph.D. as an independent member of its board of directors effective immediately. Dr. Curnutte will serve on the compensation committee. The Company also announced that Adeoye (Oye) Olukotun, M.D

A Season of Giving Is Underway at La Jolla Beach Hotel
This November and December, San Diego Marriott La Jolla is partnered with Toys for Tots to bring the joy of the holiday season to less fortunate children in their community. While guests recognize that there is no greater reward than honoring a season of giving by sharing with children in need, they also have a little something to be gained from this La Jolla beach hotel.

Overwhelming Public Support for Use of Monkeys in Ebola Vaccine Research
WASHINGTON, DC--(Marketwired - November 12, 2014) - Zogby Analytics conducted an online survey of 1,009 adults in the US and found that 64.4 percent of American adults support the use of research monkeys for the development of vaccines to protect against the Ebola virus

San Diego, CA Hotel Gives to Leukemia & Lymphoma Society This Fall
Beginning this fall and lasting through the Light the Night Walk, one hotel in La Jolla, San Diego is offering a Leukemia & Lymphoma Donation Rate to honor the organization's worthy mission. The rate is available online. For every room night reserved under this rate, San Diego Marriott La Jolla is proud to be giving $10.00 back to the Leukemia & Lymphoma Society through November 7th

Proteostasis Therapeutics Appoints Meenu Chhabra as Chief Executive Officer
Proteostasis Therapeutics, Inc., a developer of novel therapeutics regulating protein homeostasis to improve outcomes for patients with orphan and neurodegenerative diseases, today announced the appointment of Meenu Chhabra as President and Chief Executive Officer. Ms

T23 Announces Global License of Scripps' CD22 Siglec Oncoimmunological Platform for B-Cell Tumors
The Scripps Research Institute (TSRI) and T23 today announced a global agreement for the development and commercialization of ligands for CD22, one of the family of siglecs (sialic acid-binding immunoglobulin-type lectins), discovered and characterized by TSRI Professor James Paulson, PhD. Siglecs modulate cellular signaling and immune system activation and inhibition

VGTel Announces the Appointment of Advisory Board
NEW YORK, NY--(Marketwired - May 15, 2014) - VGTel, Inc.  (OTCQB: VGTL), an emerging international leader in entertainment media and film financing, today announced that Ralph Rieckermann, Christopher J. Scott and Michel Sanner, Ph.D. have been appointed to the company's Advisory Board

West Palm Beach Periodontist Sponsors 9th Annual PGA National Women's Cancer Awareness Days
Dr. Daniel Lauer, a board-certified periodontist in Palm Beach Gardens, is one of the many sponsors of the 9th Annual PGA National Women's Cancer Awareness Days (WCAD). Dr. Lauer has sponsored the event for the past five years in honor of his grandmother

The Radiant Creations Group, Inc. (RCGP) Elects Major General John A. Leide (US Army Retired) to Its Board of Directors
LAKE PARK, FL--(Marketwired - November 13, 2013) - The Radiant Creations Group, Inc. (OTCBB: RCGP) developer of unique, proprietary scientific technologies, cosmetic and over-the-counter products is proud to announce it has elected Major General John A. (Jack) Leide, USA, (Ret) to its Board of Directors beginning the start of its fourth quarter, December 1, 2013.

Viriom Expands Global Licensing Agreement With Roche for Innovative Compound Development for HIV Treatment
Today at the 4th annual Innovative Drug Research and Development in Russia Forum, Viriom LLC -- a ChemRar company announced the signing of a global expansion of Viriom's commercial rights to VM-1500, an innovative Roche candidate NNRTI (non-nucleoside reverse transcriptase inhibitor). In 2009, Viriom and Roche concluded a regional license to VM-1500 for treatment of HIV

Steven M. Tredinnick Joins Burns & McDonnell
Steven M. Tredinnick, PE, CEM, has joined Burns & McDonnell as Senior Project Manager for the company's Onsite Energy & Power Group. Tredinnick will be located with the Onsite Energy team in Burns & McDonnell's Chicago Region, focusing primarily on medical center, airport and university clients.

F1000Prime Evolves: Self-Learning Homepage and Free One-Month Personal Trial
Faculty of 1000's F1000Prime ( has launched a new personalized homepage and article alerting tool that learns from an individual's research interests - and introduced a free one-month trial personal subscription for new and returning users.

Viriom Reports Clinical Efficacy Data for VM-1500, a New HIV NNRTI
Dr. Vadim Bichko, Chief Scientific Officer of Viriom, presented positive interim results for a phase Ib/IIa study with VM-1500, a new HIV NNRTI (non-nucleoside reverse transcriptase inhibitor), at the 15th Annual International Meeting of the Institute of Human Virology (held September 8-11, 2013, in Moscow, Russia)

"Chemistry for the Future Solvay Prize" awarded to Professor Peter G. Schultz for his work at the interface of chemistry and the life sciences
Professor Schultz's work has resulted in new methods to synthesize molecules with novel chemical and biological properties and has impacted chemistry, materials science and medicine Brussels, 26 September 2013 -- The "Chemistry for the Future Solvay Prize", a bi-annual EUR 300,000 prize created by the Belgium based Solvay Group, is awarded to Professor Peter G

Achieving Commercial Success to Benefit Patients Highlighted at the Third Annual Stem Cell Meeting on the Mesa Regen Med Partnering Forum
The 2013 Stem Cell Meeting on the Mesa and its Regenerative Medicine Partnering Forum, the largest gathering of companies, major research institutions and thought leaders in the sector, will feature a candid exchange in the plenary session among senior pharmaceutical and biotech execs regarding the near term prospects for therapeutic breakthroughs

Indi Molecular Launches With $1.5 Million Seed Round Led by Interwest Partners
Indi Molecular, which pioneered a synthetic replacement for antibodies, today announced that it has raised a $1.5 million seed round led by InterWest Partners and joined by several angel investors

San Diego Golden Triangle Hotel Joins the Race for the Cure
The only thing better than enjoying an amazing meal is enjoying an amazing meal that helps out someone who may not be at the table that night. With this in mind, the San Diego Marriott La Jolla has teamed up with the Susan G. Komen Foundation to participate in the organization's Dine Out event from August 28 to 29, 2013.

Cystinosis Research Foundation Awards $1.29 Million in Grants to Find a Cure for Deadly Genetic Disease
Six grants totaling $1,295,377 were issued to cystinosis researchers investigating better treatments and a cure for the disease by the Cystinosis Research Foundation in its first round of proposals in 2013. Included is funding for additional research on stem cell and gene therapy, which holds the greatest promise to cure the rare, deadly metabolic and genetic disease

Retirement of Chief Technology Officer Werner Bauer, Appointment of Stefan Catsicas
Nestlé S.A. /Retirement of Chief Technology Officer Werner Bauer, Appointment of Stefan Catsicas . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Hotel in La Jolla, CA Completes $17-Million Renovation
This month the San Diego Marriott La Jolla will kick off the summer season with an entirely new look, and it's currently in the process of putting the finishing touches on its transformation with a few more updates to its hotel near La Jolla Shores Beach.

ChemRar Ventures and Sanofi Sign a Scouting Pharma Partnering Agreement
ChemRar Ventures announced during BIO Convention in Chicago that the scouting agreement for a venture investment in Russia and Asia was signed between ChemRar Ventures and Sanofi

Presentations at Partnerships in Clinical Trials Conference Explore How Telemonitoring Reduces Clinical Trial Costs
John Holland, head of research at AMC Health, will present "Crowd-sourcing and Telemonitoring: Better Data at Lower Cost" at the 22nd Annual Partnerships in Clinical Trials Conference in Orlando, Fla., April 21-24.

Alliance of Translational Research Centres Established to Accelerate Global Drug Development
At the Canadian High Commission in London UK today, six of the world's top translational health research centres announced they have come together to form a new Global Alliance of Leading Drug Discovery and Development Centres

Cytonics Receives Notice of Allowance for Patent Related to FACT(TM) Diagnostic for Back and Joint Pain
Cytonics Corporation, a biotechnology company focused on proteomic-based diagnostics and treatments for musculoskeletal disease, announced that the United States Patent Office has granted a Notice of Allowance for a patent related to the company's FACT™ (Fibronectin-Aggrecan Complex Test)

Cystinosis Research Foundation Awards $1.6 Million in Grants to 11 Research Projects
Grants totaling more than $1.6 million were awarded by the Cystinosis Research Foundation for 11 new research projects seeking to cure cystinosis and advance new treatments for the rare metabolic and fatal disease. The newly funded studies include research focused on corneal cystinosis, muscle wasting and stem cells

Crucell and Scripps Research Discover and Describe Broad-spectrum Antibodies against Influenza B, a Crucial Link in Development of Universal Flu Therapies and Vaccine
In a landmark discovery, researchers from Crucell Holland B.V. and The Scripps Research Institute, today announced the identification of the first human monoclonal antibodies that appear capable of disabling all influenza B viruses. The discovery, published today in the journal Science, addresses a significant missing link in development of universal therapies and a vaccine

Integrated Diagnostics(R) Launches Imaging Division to Create PET Imaging Probes
Integrated Diagnostics (InDi®), an emerging leader in molecular diagnostics, today announced that the company has launched a new operating division, InDi Imaging™, that is creating a new generation of PET imaging probes using the company's innovative protein catalyzed capture (PCC) agent technology

BrightScope Ranks San Diego Area-Based Companies With 401k Plans Containing More Than $100M in Assets
BrightScope (, a leading provider of independent financial information and investment research, today announced its second annual list of San Diego area-based companies with 401k plans containing more than $100 million in assets. This year BrightScope expanded the list to include all San Diego area-based plans that fall into this category -- 21 in total.

Wood Partners to Commence Construction on $27 Million Midtown Delray Community in Delray Beach, Fla.
Multifamily developer Wood Partners announced today that it has closed on a $26.9 million deal to build Midtown Delray, a neighborhood of 116 three-story rental townhomes near downtown Delray Beach. Construction on the new community, which will be spread across 17 buildings totaling nearly 192,000 square feet of living space, is scheduled to begin on July 1.

Cystinosis Research Foundation Raises $1.75 Million; Milestones Announced
The Cystinosis Research Foundation raised $1.75 million at its tenth anniversary celebration of Natalie's Wish and announced reaching two milestones in its search for better treatments and a cure for the rare metabolic disease that afflicts about 2,000 people, mostly children, worldwide.

New technique offers safer alternative to gene therapy for HIV treatment
Scientists at The Scripps Research Institute have found a surprisingly simple and safe method to disrupt specific genes within cells.

Anti-cocaine vaccine makes mice resistant to drug's effects
A single-dose vaccine capable of providing immunity against the effects of cocaine offers a novel and groundbreaking strategy for treating the drug addiction, according to a new study.

Neurotransmitters that lead to forgetting identified
Although we know that forgetting is normal, exactly how we forget-the molecular, cellular, and brain circuit mechanisms underlying the process-is poorly understood.

Scientists should 'cool it' on alien life claims, says biologist
Scientists and the media should stop "crying wolf" about new life forms, according to a well-known molecular biologist.

How gene duplication helped our brains become 'human'
In a new study, a team of scientists has shown that an extra copy of a brain-development gene, which appeared in our ancestors' genomes about 2.4 million years ago, allowed maturing neurons to migrate farther and develop more connections.

Antidote for cocaine overdose developed
Researchers have shed light on a treatment, which may reverse the effects of cocaine in case of emergency.

Harnessing neurons in mouse brains 'helps partially control memory'
In a new study, scientists have found a way to partially control a specific memory in mice by turning neurons in their brains on and off.

Soon, blood test may predict heart attack risk
A promising new blood test may be useful in helping doctors predict who is at risk for an imminent heart attack, say researchers.

Vitamin D may help treat Alzheimer's disease
Scientists have identified the intracellular mechanisms regulated by vitamin D3 that may help the body clear the brain of amyloid beta, the main component of plaques associated with Alzheimer's disease.

Inflammatory circuit that triggers breast cancer identified
Although it is commonly accepted that inflammation is a crucial underlying factor in various diseases, including the progression of cancer, little is known about its role when normal cells transform into tumour cells.

Therapy to eradicate malaria comes closer to reality
Researchers have completed the first-ever comparative analysis of all currently available and in-development antimalarials in terms of the steps they target in the parasite's lifecycle.

Novel compounds for treating muscular dystrophy created
Scripps Research Scientists have for the first time designed a series of small molecules that act against an RNA defect directly responsible for the most common form of adult-onset muscular dystrophy.

Soon, pill that can alter biological clock and combat obesity
Scientists have synthesized a pair of small molecules that significantly alter the core biological clock in animal models, highlighting the compounds' potential effectiveness in treating a wide range of disorders-including obesity, diabetes, high cholesterol, and serious sleep disorders.

Brain cell malfunction linked to schizophrenia
Defect in certain portions of protein that package DNA is the root cause of Schizophrenia and the deficit is especially pronounced in younger people, a new study has suggested.

New Alzheimer's drug may help prevent disease progression
A new drug candidate that may be the first capable of halting the devastating mental decline of Alzheimer's disease has been developed by scientists.

Anti-stress peptide in brain could help treat alcoholism
Scientists have highlighted the power of an endogenous anti-stress peptide in the brain to prevent and even reverse some of the cellular effects of acute alcohol and alcohol dependence in animal models.

New family of antimalarial compounds both prevents and cures disease
Washington, Nov 18 (ANI): In a new study, an international team of scientists claim to have discovered a family of chemical compounds that could lead to a new generation of antimalarial drugs capable of not only alleviating symptoms but also preventing the deadly disease

How antibody disarms HIV virus by using its sugar cloak
A new study has shed light on how one broadly neutralizing HIV antibody actually uses part of the sugary cloak to help bind to the virus and disarm it.

Gene responsible for maintaining steady weight uncovered
Scientists from the Florida campus of The Scripps Research Institute have discovered a specific gene that plays an important role in keeping a steady balance between our food intake and energy expenditure.

Treatments for asthma, allergies and arthritis to become safer
A missing link between the body's biological clock and sugar metabolism system has been discovered, which may help avoid the serious side effects of drugs used for treating asthma, allergies and arthritis.

New Alzheimer's drug may help prevent disease progression
A new drug candidate that may be the first capable of halting the devastating mental decline of Alzheimer's disease has been developed by scientists.

Promosome Announces the Appointments of Edward R. Robinson and Loren A. Busby to Its Board of Managers
Promosome LLC, a privately held biotechnology company specializing in innovative technologies related to the regulation of protein synthesis, has announced the expansion of its Board of Managers. To further augment its corporate structure and support for its technology commercialization efforts, Promosome is pleased to announce the addition of Mr. Edward R. Robinson and Ms. Loren A. Busby.

Novartis and collaborators discover new dual-acting class of antimalarial compounds with potential to both prevent and treat malaria infections
Novartis International AG /Novartis and collaborators discover new dual-acting class of antimalarial compounds with potential to both prevent and treat malaria infections . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Comment on this story